Standard Document
Fourth Edition
Microbiology

CLSI M27M44S

Performance Standards for Antifungal Susceptibility Testing of Yeasts

CLSI M27M44S includes updated minimal inhibitory concentration, zone diameter, and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents CLSI M27 and CLSI M44.

March 04, 2026
Philippe Dufresne, PhD; Nathan Wiederhold, PharmD

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Abstract

CLSI M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts includes minimal inhibitory concentration, zone diameter, and quality control tables developed following the guidance in CLSI M27 and CLSI M44. The data in the tables are valid only when the methodologies in CLSI M27 and CLSI M44 are followed. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.

Product Details
M27M44SEd4E
978-1-68440-316-5
28
Additional Details

This document is available in electronic format only.

Authors
Philippe J. Dufresne, PhD
Nathan P. Wiederhold, PharmD
Barbara D. Alexander, MD, MHS
David Andes, MD
Andrew Borman, BSc, PhD
Ryan Demkowicz, MD
Tanis Dingle, PhD, D(ABMM), FCCM
Hari Dwivedi, BVSc(DVM), MVSC, PhD
Julianne Kus, HonBSc, MSc, PhD, FCCM
Shawn R. Lockhart, PhD, D(ABMM), F(AAM)
Stephanie Mitchell, PhD, D(ABMM)
Chris Pillar, PhD
Amir Seyedmousavi, VMD, PhD, D(ABMM), FECMM
Paul E. Verweij, MD, FECMM
Zoe Freeman Weiss, MD
Sean Zhang, MD, PhD, D(ABMM)
Abstract

CLSI M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts includes minimal inhibitory concentration, zone diameter, and quality control tables developed following the guidance in CLSI M27 and CLSI M44. The data in the tables are valid only when the methodologies in CLSI M27 and CLSI M44 are followed. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.

Additional Details

This document is available in electronic format only.

Authors
Philippe J. Dufresne, PhD
Nathan P. Wiederhold, PharmD
Barbara D. Alexander, MD, MHS
David Andes, MD
Andrew Borman, BSc, PhD
Ryan Demkowicz, MD
Tanis Dingle, PhD, D(ABMM), FCCM
Hari Dwivedi, BVSc(DVM), MVSC, PhD
Julianne Kus, HonBSc, MSc, PhD, FCCM
Shawn R. Lockhart, PhD, D(ABMM), F(AAM)
Stephanie Mitchell, PhD, D(ABMM)
Chris Pillar, PhD
Amir Seyedmousavi, VMD, PhD, D(ABMM), FECMM
Paul E. Verweij, MD, FECMM
Zoe Freeman Weiss, MD
Sean Zhang, MD, PhD, D(ABMM)